Week 16 #WOTD – Can’t Score, Won’t Score

Bit of a change this week with 16 companies failing to score growth compared to 2 last week! AstraZeneca (AZN) pulled in the biggest gain at 3.2% thanks to the US clearing their proposed acquisition of Alexion Pharmaceuticals at the end of last week. Full Story This is a big step forward in their growthContinue reading “Week 16 #WOTD – Can’t Score, Won’t Score”